NDC 62332-650

Fulvestrant

Fulvestrant

Fulvestrant is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Fulvestrant.

Product ID62332-650_8e5d53bc-4b9c-49d0-aecd-eb0f8dd297ff
NDC62332-650
Product TypeHuman Prescription Drug
Proprietary NameFulvestrant
Generic NameFulvestrant
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2022-12-22
Marketing CategoryANDA /
Application NumberANDA215077
Labeler NameAlembic Pharmaceuticals Inc.
Substance NameFULVESTRANT
Active Ingredient Strength50 mg/mL
Pharm ClassesEstrogen Receptor Antagonist [EPC], Estrogen Receptor Antagonists [MoA], Selective Estrogen Receptor Modulators [MoA]
NDC Exclude FlagN
Listing Certified Through2024-12-31

Packaging

NDC 62332-650-05

2 SYRINGE in 1 CARTON (62332-650-05) > 5 mL in 1 SYRINGE (62332-650-11)
Marketing Start Date2022-12-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Fulvestrant" or generic name "Fulvestrant"

NDCBrand NameGeneric Name
0143-9022FulvestrantFulvestrant
0310-7720FulvestrantFulvestrant
0591-5019FulvestrantFulvestrant
0781-3079FulvestrantFulvestrant
0781-3492FulvestrantFulvestrant
16714-070FULVESTRANTfulvestrant
16714-118FulvestrantFulvestrant
16729-436FULVESTRANTFulvestrant
25021-462fulvestrantfulvestrant
43598-262FulvestrantFulvestrant
70121-1463FulvestrantFulvestrant
63323-715FulvestrantFulvestrant
67457-311FulvestrantFulvestrant
68462-317FulvestrantFulvestrant
70534-002fulvestrantfulvestrant
68001-424fulvestrantfulvestrant
68842-301FulvestrantFulvestrant
70860-211FulvestrantFulvestrant
71288-555FulvestrantFulvestrant
71731-6121FulvestrantFulvestrant
72603-105FulvestrantFulvestrant
0310-0720FASLODEXFulvestrant
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.